Duke Clinical and Translational Science Institute Provides Accelerator Research Funding


Deadline: November 2, 2016

The Duke CTSI Translational Accelerator Research Funding Agreements (formerly known as Collaborative Pilot Agreements) provide funding up to $150,000 (direct costs only).

Projects must demonstrate high translational potential with a clear path to subsequent financial support, new company formation, licensing, not-for-profit partnering, or other channels to enable translation to the patient care. Cross-disciplinary scientific research addressing the development of therapies, diagnostics or devices applicable to human disease, clinical research/trials (excluding Phase 2 or beyond), epidemiological studies, and/or community-based research are eligible for these awards. Population health improvement projects should demonstrate significant stakeholder involvement to advance applicability of the results to broader practice patterns, clinical guidelines, and other applications. Proposals from teams of investigators from different disciplines are encouraged.


  • Proposals must be submitted by Duke regular rank faculty and comply with the Duke University Policy on PI Status in the Duke Faculty Handbook. Researchers holding an adjunct appointment are not eligible to apply.
  • Non-Duke faculty may be named as co-investigators if they have a separate aim that will be funded by their local CTSA (subcontracts to other institutions are not allowed under this award).
  • More than one proposal may be submitted per faculty member acting as PI, but the faculty member is only eligible to receive one award as PI during a given funding cycle.
  • Faculty members may not serve as PI on more than one concurrently funded Duke CTSI award.

The CTSI uses the MyResearchProposal online application software to submit applications.